A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies

摘要

Introduction: Growing evidence supports the idea that microparticles (MPs) could contribute to the pathogenesis of the thrombotic phenomena associated with antiphospholipid antibody syndrome (APS), inducing a hypercoagulable state. But, to date, different approaches to evaluate circulating MPs and conflicting results have been reported.